Shares of Galmed Pharmaceuticals Ltd. (GLMD) skyrocketed as much as 284% in early trade on Tuesday, and as of this writing are up over 180%, following encouraging top-line, 52-week results from its study dubbed ARREST.
from RTT - Biotech https://ift.tt/2t0PrkU
via IFTTT
No comments:
Post a Comment